Beth Eaby

Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool

Alex Molassiotis, Peter Coventry, Carrie Tompkins Stricker et al. · Journal of Pain and Symptom Management · 2007 · 167 citations · Full text

Medicine, Oncology, Pharmacology +15

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

Mario E. Lacouture, Michael L. Maitland, Siegfried Segaert et al. · Supportive Care in Cancer · 2010 · 151 citations

Medicine, Dermatology, Oncology +13

Understanding the concept of chemotherapy-related nausea: the patient experience

Alex Molassiotis, Carrie Tompkins Stricker, Beth Eaby et al. · European Journal of Cancer Care · 2008 · 72 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Expert Consensus on the Management of Erlotinib-Associated Cutaneous Toxicity in the U.K.

Nicholas Thatcher, M. Nicolson, Richard Groves et al. · The Oncologist · 2009 · 38 citations · Full text

Medicine, Dermatology, Oncology +14

Gefitinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): The Expanded Access Protocol Experience at the University of Pennsylvania

Maria Luisa Veronese, Kenneth Algazy, Lisa Bearn et al. · Cancer Investigation · 2005 · 18 citations

Medicine, Pharmacology, Pharmacotherapy +14